| 000 | 01654 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511195443.0 | ||
| 264 | 0 | _c19910812 | |
| 008 | 199108s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, S C | |
| 245 | 0 | 0 |
_aClinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial. _h[electronic resource] |
| 260 |
_bCancer research _cJul 1991 |
||
| 300 |
_a3669-76 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, Surface _xanalysis |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _ximmunology |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aLung Neoplasms _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadministration & dosage |
| 700 | 1 | _aGrimm, E A | |
| 700 | 1 | _aParkinson, D R | |
| 700 | 1 | _aCarinhas, J | |
| 700 | 1 | _aFry, K D | |
| 700 | 1 | _aMendiguren-Rodriguez, A | |
| 700 | 1 | _aLicciardello, J | |
| 700 | 1 | _aOwen-Schaub, L B | |
| 700 | 1 | _aHong, W K | |
| 700 | 1 | _aRoth, J A | |
| 773 | 0 |
_tCancer research _gvol. 51 _gno. 14 _gp. 3669-76 |
|
| 999 |
_c1654918 _d1654918 |
||